These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 7054735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
    Larsson B, Hagström B, Viberg L, Anker C, Hamberger L, Lindhe BA.
    Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with today's IUDs.
    Pasquale S.
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S25-9. PubMed ID: 8972499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G, Amatya R, Acosta M, Ekwempu C, Kisninci H.
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC.
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA.
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [Abstract] [Full Text] [Related]

  • 13. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA, Aisien AO.
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B, Rodau S, Patek E.
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [Abstract] [Full Text] [Related]

  • 16. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM, Cosmi EV.
    Patol Clin Ostet Ginecol; 1984 Jul; 12(4):331-43. PubMed ID: 12340352
    [Abstract] [Full Text] [Related]

  • 17. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I, Stern J, Diaz J, Diaz MM, Faundes A, el Mahgoub S, Diaz S, Pavez M, Coutinho E, Mattos CE.
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J.
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.